Your session is about to expire
← Back to Search
Electroanatomic Mapping for Tetralogy of Fallot
Study Summary
This trial is looking at individuals with repaired Tetralogy of Fallot who are at risk for sudden cardiac death from ventricular tachycardia. The goal is to identify which individuals are at risk and to explore the feasibility of a new technology to help distinguish between slow conduction and conduction block.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been diagnosed with tetralogy of Fallot (TOF) or double outlet right ventricle (DORV).You have been recommended to get a transcatheter pulmonary valve replacement for your heart as part of your regular medical care.
- Group 1: RV mapping
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any openings for potential participants in this research endeavor?
"According to clinicaltrials.gov, the recruitment phase for this experiment is currently active. It was initially uploaded on September 1st 2022 and last updated on August 5th 2022."
How many individuals are participating in the trial at its peak capacity?
"Affirmative. Clinicaltrials.gov records show that this medical experiment, which first appeared on September 1st 2022, is currently recruiting patients. There are 60 spots available at a single clinical site."
Share this study with friends
Copy Link
Messenger